Lack of Newly Acquired Information Defeats Plaintiffs' Claims in Zofran MDL | Faegre Drinker Biddle & Reath LLP

Zofran (ondansetron) has often been used to combat nausea during pregnancy. It has never been approved by the FDA for that indication, but clinical experience has not supported an...

Related Keywords

Japan ,United Kingdom ,Japanese , ,Faegre Drinker Biddle Reath ,Boehringer Ingelheim Pharms Inc ,Faegre Drinker Biddle ,First Circuit ,Products Liability Litigation ,Changes Being Effected ,Ingelheim Pharms ,